Searched for
EMTRICITABINE
Strides Pharma gets USFDA nod to market HIV drugThe company's product is bioequivalent and therapeutically equivalent to Atripla Tablets of Gilead Sciences LLC, it added. As per per IQVIA...04 Oct, 2023, 04.24 PM IST- Lupin gets tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide tabletsThe tentative approval by the United States Food and Drug Administration (USFDA) has been granted under the President's emergency plan for ...31 Jan, 2023, 01.03 PM IST
- Zydus Cadila gets USFDA nod to market generic HIV infection treatment tabletsThe drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad. The drug is used with other HIV medicati...02 Jul, 2021, 02.05 PM IST
- Lupin launches generic HIV-1 drug in USThe drug maker's product is the generic version of Gilead Sciences, Inc's Truvada tablets and indicated in combination with other antiretro...25 Jun, 2021, 10.26 PM IST
- Lupin gets USFDA nod to market generic HIV drugThe company has received approval from the United States Food and Drug Administration (USFDA) to market its Emtricitabine and Tenofovir Dis...07 Jun, 2021, 03.54 PM IST
- Strides Pharma Science arm gets USFDA nod for HIV treatment drugDrug firm Strides Pharma Science on Friday said its step-down wholly-owned subsidiary, Strides Pharma Global, has received approval from th...15 Jan, 2021, 10.45 AM IST
- Cipla ready to launch low dose HIV drug 'Efavirenz'Drug major Cipla Ltd today said it is ready to launch low dose 'Efavirenz' used in treatment of HIV infection.30 Nov, 2015, 12.41 PM IST
- Strides Arcolab gets USFDA nod for anti-AIDS combination drugDrug firm Strides Arcolab today said it has received tentative approval from the US health regulator for anti-AIDS combination drug.01 Aug, 2013, 05.24 PM IST
- Shilpa Medicare inks pact with MPP, Gilead for HIV/AIDS drugsShilpa Medicare inked an agreement with Gilead Sciences to increase access to medicines used for treatment of HIV/AIDS.27 Jun, 2013, 06.36 PM IST
- Aurobindo Pharma gets tentative nod from USFDA for Anti-AIDS drugAurobindo Pharma today said it has received tentative approval from the US health regulator to manufacture and market its anti-AIDS combina...03 Apr, 2013, 01.00 PM IST
- Cipla launches four in one drug for HIV patientsIndia’s second largest drug company Cipla has launched Qvir, a combination of four HIV drugs in one single strip.14 Aug, 2012, 07.14 PM IST
- Cipla launches HIV/AIDS treatment kit at Rs 158Drug major Cipla today said it has launched 'Qvir', a four-drug kit priced at Rs 158 per kit to be used for treating HIV/AIDS.14 Aug, 2012, 05.38 PM IST
- Strides signs pact with Gilead Sciences to promote HIV drugStrides Arcolab said it has inked a pact with US-based Gilead Sciences to sell low-cost generic versions of latter's HIV medicine 'emtricit...07 Aug, 2012, 02.25 AM IST
- Strides Arcolab inks pact with Gilead Sciences to promote HIV drugStrides has inked a pact with Gilead Sciences Inc to sell low-cost generic versions of latter's HIV medicine 'emtricitabine' in developing ...06 Aug, 2012, 02.49 PM IST
- Gilead Sciences inks deals with 3 Indian companies including Ranbaxy Laboratories for low-cost HIV drugGilead Sciences has signed deals with 3 Indian firms to collaborate on promoting access to HIV medicine emtricitabine in developing nations.02 Aug, 2012, 09.22 PM IST
- Hetero Labs to produce Gilead's HIV drugs, through Medicines Patent PoolHyderabad based Hetero labs through an agreement with Geneva based Medicines Patent Pool will produce four key HIV drugs developed by Gilea...31 Jul, 2012, 04.08 PM IST
- Ranbaxy inks pact with Gilead for three generic HIV/AIDS drugsRanbaxy has entered into an agreement with US-headquartered Gilead Sciences to manufacture and market three new generic HIV/AIDS drugs.12 Jul, 2011, 02.47 PM IST
Load More
